MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Quantitative oculomotor assessment and non-motor biomarkers in late-onset GM2 gangliosidosis

    C. Stephen, D. Balkwill, P. James, K. Sassower, J. Schmahmann, R. Lewis, F. Eichler (Boston, MA, USA)

    Objective: To assess whether quantitative eye movement measures correlate with disease severity in late-onset GM2 gangliosidosis, and to perform exploratory assessments of novel cognitive/neuropsychiatric measures…
  • 2018 International Congress

    Longitudinal follow-up of dual-lead thalamic deep brain stimulation for patients with treatment refractory multiple sclerosis tremor

    B. Patel, R. Barmore, A. Elkouzi, P. Zeilman, X. Bai, L. Almeida, K. Foote, M. Okun (Gainesville, FL, USA)

    Objective: To report long-term outcome measurements of tremor control in patients with medically refractory multiple sclerosis tremor and dual lead thalamic deep brain stimulation. Background:…
  • 2018 International Congress

    Comparison of Mattis and MOCA testing for neuropsychological assessment in the preoperative evaluation of subthalamic nucleus stimulation in Parkinson´s disease

    L. Prilop, M. Alsalem, A. Gulberti, C. Gerloff, C. Buhmann, W. Hamel, C. Moll, J. Köppen, M. Pötter-Nerger (Hamburg, Germany)

    Objective: The aim of the current study is to evaluate, whether 1. MOCA (Montreal Cognitive Assessment) and Mattis tests are equivalent in the detection of…
  • 2018 International Congress

    Comparative results between preoperative acute levodopa challenge test and deep brain stimulation

    D. Fitas, M.J. Rosas, J. Parada Lima, C. Reis, P. Linhares, R. Vaz (Viana do Castelo, Portugal)

    Objective: Our aim is to compare motor clinical benefits after acute levodopa challenge test, with those obtained further with deep brain stimulation (DBS). Background: DBS…
  • 2018 International Congress

    Deep brain stimulation for monogenic Parkinson’s disease: A systematic review

    T. Kuusimäki, J. Korpela, E. Pekkonen, M. Martikainen, A. Antonini, V. Kaasinen (Turku, Finland)

    Objective: The aim was to systematically investigate the outcome of deep brain stimulation (DBS) in genetic Parkinson’s disease (PD) compared to the patients with documented…
  • 2018 International Congress

    Long-term effect of low frequency stimulation of STN on dysphagia, freezing of gait and other motor symptoms in PD

    T. Xie, L. Bloom, M. Padmanaban, B. Bertacchi, W. Kang, A. Dachman, E. MacCracken, C. Zadikoff, K. Markopoulou, P. Warnke, U. Kang (Chicago, IL, USA)

    Objective: To evaluate the long-term effect of 60Hz low frequency stimulation (LFS) of the subthalamic nucleus (STN) on dysphagia, freezing of gait (FOG) and other…
  • 2018 International Congress

    Directional DBS; clinical experience at Unit of Functional Neurosurgery. Ramón y Cajal University Hospital,Madrid, Spain

    M. del Alamo, I. Martinez-Camacho, L. Cabañes, I. Regidor, M. Villadoniga, J. Garcia-de-la-Cruz, I. Avilés-Olmos (Madrid, Spain)

    Objective: to determine the practicabillity of using an image guide programming setting in our clinical practice. Background: The applicability of DBS leads and systems that…
  • 2018 International Congress

    Deep Brain Stimulation in Tourette Syndrome: Two illustrative cases

    X. Garcia, J. Espinoza, G. Arango (Bogota, Colombia)

    Objective: To describe two cases of patients with pharmacological refractory Tourette syndrome who underwent DBS in a single center in Bogota Colombia from 2012 -2015.…
  • 2018 International Congress

    Cerebrotendinous Xanthomatosis: A Rare Lipid Storage Disease

    H. Hanagasi, G. Yunisova, B. Bilgic, O. Dogu, H. Kaleagasi, Z. Tufekcioglu, E. Lohmann, H. Gurvit, M. Emre (Istanbul, Turkey)

    Objective: Cerebrotendinous xanthomatosis (CTX) is a rare autosomal recessive lipid storage disease. It is caused by the deficiency of mitochondrial enzyme sterol 27-hydroxylase due to…
  • 2018 International Congress

    Evaluation of Balance in Hereditary Ataxias

    H. Teive, B. Zeigelboim, R. Santos, S. Dias, N. Mello, V. Fonseca (Cuitiba, Brazil)

    Objective: To describe and compare the vestibular findings most evident among the hereditary ataxia, as well as correlate their clinical aspects to the study of…
  • « Previous Page
  • 1
  • …
  • 154
  • 155
  • 156
  • 157
  • 158
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley